Recent data from the Swiss National Bank (SNB) indicates a surge in foreign currency reserves, potentially paving the way for a weaker Swiss franc. This development has led analysts to upgrade Swiss stocks, citing their resilience and appeal to investors.
Pharmaceutical and food companies, prominent in the Swiss index, are expected to benefit from a depreciating franc due to their stable demand. Nomura’s currency strategist suggests a trend towards ’short Swiss‘ trading, while Bank of America predicts Swiss stocks to outperform European stocks by 8% by year-end, rating them as „overweight.“
We’re ready to help you navigate these opportunities for your customers. Reach out to us to explore our solutions. (Kontakt)